Data from a post-hoc analysis of the Phase 3 clinical trial of Stelara® (ustekinumab) for treatment of people with moderate-to-severe lupus further validates the value of the Lupus Foundation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback